Although increased GDNF levels in the central nervous system (CNS) may be beneficial to the treatment of neurodegenerative diseases, such as PD and drug addiction [5], [6], the therapeutic application of GDNF is limited because efficient methods of delivering it to the CNS are currently not available. The gene discussed is GDNF; the disease is Parkinson disease.